Steve Duffy

Most Recent Articles by Steve Duffy

FDA Grants Orphan Drug Status to Angelman Syndrome Treatment

FDA Grants Orphan Drug Status to Angelman Syndrome Treatment

By

Delay or lack of speech, seizures, and walking/balance disorders are some of the symptoms associated with AS.

Anti-CD47 Antibody Granted Orphan Drug Designation for Multiple Myeloma

Anti-CD47 Antibody Granted Orphan Drug Designation for Multiple Myeloma

By

The FDA has granted Orphan Drug designation to Surface Oncology's lead investigational candidate SRF231, a potential treatment for patients with multiple myeloma.

New Formulation of Status Epilepticus Treatment To Be Reviewed

New Formulation of Status Epilepticus Treatment To Be Reviewed

By

The NDA for IM/IV Captisol-Enabled Fosphenytoin has been accepted for review and given a Prescription Drug Fee User Act date, by the FDA.

Should Genealogy Data Be Used for Criminal Justice Purposes?

Should Genealogy Data Be Used for Criminal Justice Purposes?

By

Informed consent, privacy, and justice concerns are 3 issues that should be addressed before the use of online genealogy data in criminal cases becomes widely adopted.

NDA for First-of-Its-Kind Opioid Analgesic Submitted to FDA

NDA for First-of-Its-Kind Opioid Analgesic Submitted to FDA

By

A NDA has been submitted for NKTR-181, an opioid analgesic molecule designed to provide pain relief with fewer CNS-mediated side effects.

More Articles by Steve Duffy

Sign Up for Free e-newsletters



CME Focus